Elekta introduces tool to manage lung tumor motion

Elekta, the Stockholm-based developer of treatment planning systems for radiation therapy and radiosurgery, has released a tool for the treatment of lung tumors that allows doctors to visually confirm a tumor’s position during the breathing cycle by allowing the lesion to be treated with a continuous radiation beam.

Lung tumors have provided a challenging radiation target because a patient’s breathing causes the target to move, but according to Elekta, its XVI Symmetry and XVI Intuity, can change the approach to treating the tumors. Symmetry provides the tools to manage shifts in the in the relative positions of the tumor and organs-at-risk during the respiratory cycle, the company said, while  Intuity ensures that not only is the tumor's position accounted for, but also the position of nearby healthy critical structures.

Intuity and Symmetry were developed in collaboration with Elekta's clinical partner, the Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital in Amsterdam.

Michael Bassett,

Contributor

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.